Q
Quoin Pharmaceuticals, Ltd. (QNRX)
NCM – Real Time Price. Currency in USD
6.41
-1.16 (-15.27%)
At close: Mar 27, 2026, 4:00 PM EDT
6.70
+0.29 (4.52%)
After-hours: Mar 27, 2026, 7:42 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
6.41
-1.16 (-15.27%)
At close: Mar 27, 2026, 4:00 PM EDT
6.70
+0.29 (4.52%)
After-hours: Mar 27, 2026, 7:42 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.04 | 6.05 | 7.0 | |
| Quick ratio | 1.04 | 5.63 | 7.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 5.2 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -104K | -104K | -103K | -100K | -101K |
| Operating Income | -5M | -8M | -9M | -10M | -14M |
| Net Income | -21M | -9M | -9M | -9M | -14M |
| EBITDA | -4M | -8M | -9M | -9M | -14M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 67.18 | 5.5 |
| Next quarter | N/A | 69.85 | 5.5 |
| Current year | N/A | 69.85 | 5.5 |
| Next year | N/A | 78.27 | 5.5 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -5.06 | -6.84 | 40.33 | 5.5 |
| Y/Y | 999 | -68.3 | 59.21 | -2.54 | 5.5 |
| 3y average | 999 | 19.95 | 84.61 | -14.39 | 7.5 |
| 5y average | 999 | -160.54 | 84.61 | -58.25 | 5.5 |
| Weighted average score | 6.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Cash reserves $1.8M barely cover the upcoming debt maturities $0.0
Total current assets $6.0M exceed Total current liabilities $5.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$2.2M limits the company's ability to reinvest or pay down debt